Notice to Extend Application Due Dates for PAR-21-309 and PAR-21-310, "Imaging - Science Track Award for Research Transition (I/START)"
April 4, 2024
Related Announcements
- August 2, 2021 - Imaging - Science Track Award for Research Transition (I/START) (R03- Clinical Trial Optional). See NOFO PAR-21-310
- August 2, 2021 - Imaging - Science Track Award for Research Transition (I/START) (R03- Basic Experimental Studies with Humans Required). See NOFO PAR-21-309
Issued by
National Institute on Drug Abuse (NIDA)
Purpose
This notice extends the expiration dates for the following funding opportunities:
- Imaging - Science Track Award for Research Transition (I/START) (R03- Clinical Trial Optional). See NOFO PAR-21-310
- Imaging - Science Track Award for Research Transition (I/START) (R03- Basic Experimental Studies with Humans Required). See NOFO PAR-21-309
New Expiration Date: January 8, 2025(Prior Date September 9, 2024).
As part of the extension, additional application due date(s) (in Bold Italic) have been added to the key dates section of the opportunities as follows:
Application Due Dates | Review and Award Cycles | ||||
New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
October 16, 2021 * | November 16, 2021 * | January 07, 2022 * | March 2022 | May 2022 | July 2022 |
February 16, 2022 * | March 16, 2022 * | May 07, 2022 * | July 2022 | August 2022 | December 2022 |
June 16, 2022 * | July 16, 2022 * | September 07, 2022 * | November 2022 | January 2023 | April 2023 |
October 16, 2022 * | November 16, 2022 * | January 07, 2023 * | March 2023 | May 2023 | July 2023 |
February 16, 2023 * | March 16, 2023 * | May 07, 2023 * | July 2023 | August 2023 | December 2023 |
June 16, 2023 * | July 16, 2023 * | September 07, 2023 * | November 2023 | January 2024 | April 2024 |
October 16, 2023 * | November 16, 2023 * | January 07, 2024 * | March 2024 | May 2024 | July 2024 |
February 16, 2024 * | March 16, 2024 * | May 07, 2024 * | July 2024 | August 2024 | December 2024 |
June 16, 2024 * | July 16, 2024 * | September 07, 2024 * | November 2024 | January 2025 | April 2025 |
October 16, 2024 | November 16, 2024 | January 7, 2025 | March 2025 | May 2025 | July 2025 |
Expiration Date
January 8, 2025
All other aspects of the opportunity(ies) remain the same.
Inquiries
Please direct all inquiries to:
John Fedota, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-402-0812
Email: john.fedota@nih.gov
and Human Services (HHS)
